Medicine & The Common Man

1. Executive Summary

Healthcare systems worldwide stand at a critical juncture. Rising costs, aging populations, workforce shortages, persistent inequities in access, and the lingering aftershocks of the COVID-19 pandemic have created unprecedented pressure on health systems across every region. This 2026 edition incorporates the latest OECD, WHO, and health expenditure data to provide an evidence-based assessment of the global healthcare landscape.

Key Findings

• Healthcare spending as a share of GDP varies dramatically: the United States spends 18.0% of GDP on healthcare by CMS's National Health Expenditure measure (17.2% on the narrower OECD-comparable consumption basis) — nearly double the OECD average — yet ranks near the bottom on life expectancy and affordability among peer nations. Germany spends 12.7%; EM7 emerging economies allocate only 2.4% of GDP to government health spending.
• The global workforce is buckling: as of early 2026, 61% of healthcare workers report moderate-to-extreme burnout. Among nurses, 53% report burnout in the past two years, and 24% are considering leaving the profession. WHO projects a global shortfall of 11 million health professionals by 2030.
• Fiscal pressure is intensifying: health official development assistance (ODA) is projected to fall 29–46% from 2024 to 2026 — roughly $5–8 billion. Aid for malaria falls 59.6%, tuberculosis 57.2%, reproductive health 54.1%.
• India trails its peers: India spends 1.8% of GDP on health, less than half of Brazil (10%) and South Africa (9%), and below Russia (7%) and China (6%). Out-of-pocket payments across BRICS countries exceed 50% of current health expenditure.

2. Introduction: The Global Healthcare Landscape

The landscape of global healthcare is as diverse as it is complex, with each country's system reflecting its unique socioeconomic, political, and cultural context. From market-driven systems to publicly funded models and hybrid approaches, nations have developed distinct strategies to deliver quality care to populations with finite resources.

2.1 The Fiscal Reality in 2026

Governments face a fast-changing and complex policy landscape with real implications for national budgets. Public finances carry multiple simultaneous pressures — ageing populations, healthcare, and defence — compounded by a declining potential growth rate in many economies. Almost 90% of OECD countries are seeking savings in social protection and/or health spending, which now accounts for 51% of public expenditure. OECD public debt has risen from 73% of GDP in 2007 to around 110% in 2024.

2.2 Why This Analysis Matters

The COVID-19 pandemic exposed vulnerabilities in every healthcare system, from surveillance failures to workforce burnout and supply chain disruption. The 2026 data confirms that while some progress has been made, the fundamental challenges remain unresolved — and in several cases have deepened.

3. The Case for Action: Why Healthcare Reform Matters

Healthcare is both a moral imperative and an economic necessity. The human cost of inadequate healthcare is measured in suffering and shortened lives; the economic cost in lost productivity, household bankruptcy, and the crowding out of other national priorities.

3.1 The Widening Equity Gap

Health inequalities between emerging market (EM) and advanced economies persist despite converging economic development. Government health expenditure in EM7 averages only 2.4% of GDP, against 8.4% in the EU-27 and 10.7% in the United States, while out-of-pocket payments exceed 50% in BRICS countries. Despite these constraints, EM7 achieves a mean life expectancy of 73.5 years, against roughly 80.5 in the EU-27 and 77.0 in the United States — a relatively favourable outcome given the resource gap.

Multivariable regression analysis shows strong explanatory power (R² = 0.77; Adj. R² = 0.71), identifying the Human Capital Index (HCI) as the dominant predictor of life expectancy (β = 39.97, p < 0.001). Human capital, not health spending alone, is the central lever of health outcomes — pointing policy toward investment in human capital formation, healthcare capacity, and digital health tailored to fiscal constraints.

3.2 The Global Workforce Crisis

The global health workforce is approaching a breaking point, driven by administrative overload, inefficient workflows, burnout, and accelerating retirements — a projected global shortfall of 11 million health professionals by 2030 (WHO).

Per the American Medical Association, roughly 61% of healthcare workers report moderate-to-extreme burnout as of early 2026. Physician burnout has improved to 42% in 2025, down from 48% in 2023 — but burnout among nurses and frontline staff remains at crisis levels: 53% of nurses report burnout in the past two years, and 24% are considering leaving the profession.

The Asia-Pacific region holds 60% of the world's population yet accounts for only 22% of global healthcare spending. Emerging Asia-Pacific countries average roughly 1.6 doctors per 1,000 people, against a WHO-recommended minimum of 2.5 and an OECD average of 3.7.

4. Country-by-Country Analysis

🇺🇸 4.1 United States: High Cost, Inequitable Access

Overview. The United States operates a predominantly market-driven healthcare system characterised by high spending, cutting-edge medical technology, and a strong emphasis on specialist care. Employer-sponsored private insurance is the primary coverage source for working-age Americans.

Exorbitant Spending, Poor Outcomes. The US devoted 18.0% of GDP to healthcare in 2024 by CMS's National Health Expenditure measure — nearly double the OECD average. Yet American life expectancy reached only 79 years, among the shortest in the OECD. Japan, Spain, and Switzerland each outpace the US by nearly five years; only Mexico and Turkey fared worse.

Primary Care Shortage. Primary care supply is 0.3 physicians per 1,000 people, against the OECD average of 1.1. Annual physician production is 8.6 per 100,000, constrained by tuition costs, residency slot limits, underinvestment, and burnout.

Affordability Crisis. Despite spending the most, the US ranks near the bottom on affordability. Roughly one-third of US adults have made at least one trade-off with daily living expenses to afford healthcare.

Solutions: value-based care rewarding outcomes over procedure volume; expanded residency slots and loan forgiveness to address the primary care shortage; continued ACA-driven coverage expansion.

🇨🇳 4.2 China: Scale and Centralised Control

Overview. China's healthcare system operates within the world's largest population. The government has shown a capacity for centralised cost control that may be unique among major economies — health spending sits at roughly 6% of GDP, well above India's allocation.

Problems: a massive population creates real logistical challenges in delivery; significant urban-rural access gaps persist; the world's largest elderly cohort strains public health resources; China accounts for 7.4% of global TB cases, against India's 28%.

Solutions: government-driven cost controls (China may be the only country achieving negative medical inflation through centralised policy); the "Healthy China 2030" prevention-first strategic plan; heavy investment in telemedicine and integrated care.

🇷🇺 4.3 Russia: Transition and Modernisation

Overview. Russia is a middle-income country navigating the transition from Soviet-era centralised healthcare toward modern infrastructure — health spending stands at roughly 7% of GDP.

Problems: legacy Soviet-era infrastructure requiring modernisation; policy focus shifted toward post-COVID emergency preparedness; acute workforce shortages and brain drain in rural areas; geopolitical constraints on health-sector resources.

Solutions: hospital infrastructure upgrades; digital health and telemedicine investment; strengthened cardiovascular prevention and substance-abuse programmes.

🇸🇦 4.4 Saudi Arabia: Wealth With Workforce Gaps

Overview. Saudi Arabia represents the intersection of national wealth and workforce development challenges common across Gulf nations.

Problems: heavy reliance on expatriate healthcare workers raises sustainability concerns; specialised care gaps remain; rising non-communicable disease burden including diabetes and obesity.

Solutions: domestic medical education and retention strategies; telemedicine and integrated data systems; comprehensive diet and exercise prevention programmes.

🇩🇪 4.5 Germany: Excellence Under Strain

Overview. Germany runs a dual public-private system with mandatory health insurance, spending 12.7% of GDP on health — among the highest in Europe, though significantly below the US rate.

Problems: population ageing increases demand while the workforce shrinks; a complex multi-payer system creates administrative inefficiency.

Solutions: health technology assessment and drug price negotiation; expanded integrated care and digital health; strengthened chronic-disease prevention.

🇮🇳 4.6 India: The Burden of Out-of-Pocket Spending

Overview. India's healthcare system is vast and complex — a mixed system with substantial public and private sector presence.

Stagnant Government Spending. India's health budget has inched from 1.4% to 1.8% of GDP from FY20 to FY26 (budget estimates), while education spending has actually declined from 2.9% to 2.7% over the same period.

BRICS Comparison. India's 2023 health expenditure was less than half of Brazil's (10%) and South Africa's (9%), and below Russia (7%) and China (6%) — also lagging the lower-middle-income country average of 3.4%.

Out-of-Pocket Burden. The BRICS subgroup carries the most acute private-financing burden, with 52.5% of health spending from private sources.

Nutrition Crisis. 81 crore people receive only 5kg of free food grain monthly — enough for subsistence, not for the nutritional adequacy good health requires.

Solutions: the National Health Mission and Ayushman Bharat (PM-JAY), providing free coverage at secondary/tertiary level for the bottom 40% of the population; AI-assisted TB screening via chest X-ray, already in active use; strengthened nutrition and food security programmes.

🇯🇵 4.7 Japan: Super-Ageing Society

Overview. Japan holds one of the world's highest life expectancies — nearly five years longer than the United States — under universal coverage, spending roughly 11.5% of GDP on health.

Problems: the world's most rapidly ageing population strains chronic and long-term care capacity against a shrinking workforce; the healthcare workforce itself is ageing and hard to replenish.

Solutions: generics and biosimilars promotion; community-based care to reduce hospital dependence; investment in robotics and AI to augment caregiving capacity.

5. Cross-Cutting Global Challenges

5.1 The Workforce Crisis Deepens

The global health workforce is approaching a breaking point — a projected shortfall of 11 million health professionals by 2030. Per the American Medical Association, roughly 61% of healthcare workers report moderate-to-extreme burnout as of early 2026. Physician burnout has improved to 42% (from 48% in 2023), but burnout among nurses and frontline staff remains at crisis levels. Two distinct types are worth separating in any organisational response:

• Workload burnout — driven by long hours, heavy patient loads, and relentless cognitive demand. It responds well to better scheduling, smarter systems, automation, and AI tools. This is the type improving for physicians.
• Toxic burnout — far more dangerous, and not workload-driven. It stems from chronic understaffing, workplace violence, normalised incivility, absent leadership, and cultures where speaking up costs more than staying silent.

2026 Nurse Salary and Work-Life Report: 53% report burnout in the past two years; 62% report feeling overwhelmed; 24% are considering leaving the profession. Top drivers: salary dissatisfaction (49%), unresponsive leadership (48%), unmanageable nurse-to-patient ratios (48%).

5.2 Healthcare Costs: Impact on Individuals and Economies

Official development assistance for health faces the steepest cuts of any sector: a projected 29–46% fall from 2024 to 2026, roughly $5–8 billion. Net ODA overall is projected to fall to $152 billion in 2026 — a third consecutive year of decline. Disease-specific aid faces particularly severe cuts: malaria (-59.6%), tuberculosis (-57.2%), reproductive health (-54.1%).

OECD public debt has risen from 73% of GDP in 2007 to roughly 110% in 2024. Almost 90% of OECD countries are seeking savings in social protection and/or health spending, now 51% of public expenditure.

5.3 Digital Health and AI: Promise and Peril

AI is better framed as a retention strategy — preserving careers, expertise, and the human core of care — than as a substitute for clinicians. High-impact uses include ambient documentation, coding support, scheduling and demand prediction, and inbox triage. AI is genuinely helping with workload burnout — a real, measurable factor in physician burnout's 2026 improvement.

AI cannot solve toxic burnout. It cannot fix understaffing, prevent workplace violence, replace visible and present leadership, or rebuild trust between frontline staff and executives.

5.4 Health Equity in Emerging Markets

EM7 government health expenditure averages just 2.4% of GDP, against 8.4% in the EU-27 and 10.7% in the US, while out-of-pocket payments exceed 50% across BRICS countries. A statistically significant negative correlation between government and private health expenditure appears across all 36 countries studied (Pearson r = −0.67, p < 0.001) — stronger public financing tends to crowd out private out-of-pocket burden.

Digital health readiness remains significantly lower in emerging markets: EM7 scores 3.68/5, against 4.37/5 in the EU-27 and 5.0/5 in the US.

6. Common Solutions and Best Practices

6.1 Primary Care Investment

Strong primary care systems consistently show better outcomes at lower cost. The US, at 0.3 primary care physicians per 1,000 people against an OECD average of 1.1, demonstrates the cost of underinvestment directly.

6.2 Workforce Retention — Five Strategies That Actually Work

• Separate the two types of burnout in your data — break it out by role, team, and shift
• Audit your AI strategy through a culture lens — does it make the work better, or just make more work possible?
• Bring frontline staff into AI decisions on day one
• Lead visibly through the discomfort — toxic burnout shrinks when leaders show up, repeatedly
• Measure what matters — psychological safety and trust in leadership, not just turnover and survey scores

6.3 Cost Containment

Price negotiation, health technology assessment, generic and biosimilar promotion, value-based payment models, and integrated data systems all recur as effective levers across the country sections above.

6.4 Prevention and Public Health

Prevention remains the single most cost-effective approach to healthcare. Addressing underlying determinants — nutrition, environment, lifestyle, socioeconomic factors — reduces long-term spending directly.

7. Recommendations for Policymakers

7.1 Immediate Actions

• Protect coverage and affordability — extend premium subsidies, protect Medicaid and safety-net programmes
• Separate workload burnout from toxic burnout in workforce data, and invest in visible leadership
• Expand primary care training capacity and loan forgiveness
• Reverse the steep cuts to health ODA, especially for malaria, TB, and infectious disease control

7.2 Medium-Term Strategies

• Interoperable electronic health records and telehealth expansion for underserved areas
• Drug price negotiation and payment/delivery reform
• Chronic disease prevention and health promotion programmes
• Increase government health expenditure in emerging economies to reduce out-of-pocket burden

7.3 Long-Term Vision

• Universal coverage regardless of ability to pay
• Human capital formation as the central lever of health outcomes
• Pandemic preparedness and South-South cooperation
• Sustainable, low-carbon healthcare infrastructure

8. The Economics of Healthcare

The preceding sections describe healthcare systems. This section makes the economic case explicit — because the argument for reform is not only moral, it is a straightforward return-on-investment calculation.

8.1 The Productivity Drain of Poor Health

Lost productivity and reduced labour-force participation linked to poor health are projected to rise from roughly 17% of global GDP today to 23% by 2050 — not because disease is becoming more common, but because populations are living longer with chronic illness rather than dying from it. Average time lived with illness rose from about 8.7 years in 2000 to 10.2 years in 2025, and is projected to reach 11.4 years by 2050.

8.2 The Cost of Chronic Disease

In the United States alone, chronic disease is on pace to cost $47 trillion between 2024 and 2039 — $2.2 trillion annually in direct medical costs, and nearly $900 billion a year in lost productivity by 2039. Chronic conditions already drive $4.9 trillion of the US's annual healthcare bill. The same pattern repeats globally: earlier estimates placed the worldwide economic burden of non-communicable disease at roughly $47 trillion between 2010 and 2030 — a figure so large it is frequently mis-cited as US-specific, when it is in fact global, underscoring how consistently large this burden appears across independent studies.

8.3 The Return on Prevention

Better prevention, earlier intervention, and improved chronic-disease management — particularly around obesity — could prevent 150 million new chronic disease cases, save 13.5 million lives, and avoid $7 trillion in costs in the US alone between 2024 and 2039. Globally, scaling proven, cost-effective interventions could avert 35% of total disease burden by 2050, avoid 33 million premature deaths, and avert more than 461 million years of poor health annually — equivalent to roughly 18 additional healthy days per person, every year.

8.4 What AI Is Actually Worth, Economically

Separate from the workforce-retention case in Section 5.3, AI carries a distinct, independently-estimated economic value. Multiple independent analyses — McKinsey, the National Bureau of Economic Research, and a Harvard-led Health Affairs Scholar study — converge on the same range: wider AI adoption could save the US healthcare system 5–10% of total spending, or roughly $200–360 billion annually, primarily through administrative automation. That convergence across independently-conducted studies is itself notable — this is not one optimistic projection landing alone.

US hospitals spent $687 billion on administration in 2023, against $346 billion on direct patient care — a roughly 2:1 ratio. AI's $200–360 billion savings estimate would claw back a substantial share of that imbalance without touching clinical care itself.

8.5 Spending Level Alone Does Not Buy Outcomes

The country data in Section 4 makes this concrete: the United States spends 18.0% of GDP on healthcare and achieves a 79-year life expectancy; Japan spends 11.5% and achieves roughly 84 years. Beyond a certain point, additional spending appears to buy administrative complexity more reliably than additional years of life.

9. Healthcare 2035 — What's Already Real, and What Isn't Yet

Forward-looking sections in healthcare writing tend toward one of two failure modes: reading as settled fact when they are genuinely speculative, or hedging so heavily they say nothing useful. In keeping with NGE's own standard elsewhere — dated, falsifiable claims rather than vague forecasting — this section separates what is already real and scaling today from what remains genuinely uncertain.

9.1 Already Real and Scaling

• AI-assisted diagnostics — already deployed at meaningful scale, including India's own AI-assisted chest X-ray screening for TB, in active use today, not a pilot.
• Ambient clinical documentation — already the leading driver of the physician-burnout improvement documented in Section 5.1, present-tense, not a 2035 prediction.
• Wearable continuous monitoring — consumer-grade continuous glucose and cardiac monitoring is commercially available now; the open question is integration into formal care pathways.
• Telemedicine and remote care — cited throughout this paper's country sections as an active reform tool in the US, China, Russia, Saudi Arabia, and Japan.

9.2 Genuinely Uncertain — Timeline and Scale Both Open

• Widespread robotic surgery — real and growing in specific procedures, but a general-purpose expansion timeline is genuinely unclear.
• Digital twins for individual patients — an active, well-funded research direction, but full clinical deployment at population scale by 2035 is an assumption, not a documented trajectory.
• "Home hospitals" at scale — small, real pilots exist; whether this becomes standard infrastructure depends more on reimbursement policy than on technology readiness.
• Broad gene therapy access — real, approved therapies exist for specific rare conditions today; the honest constraint is cost and manufacturing scale, not scientific feasibility.

The pattern across both lists is consistent with this paper's central argument: the technology is very rarely the actual constraint. Financing, workforce, policy, and institutional capacity are.

10. Conclusion

The exploration of healthcare systems around the world reveals a rich diversity, reflecting the distinct cultural, economic, and political landscape of each country. The 2026 data paints a sobering picture: fiscal pressure is intensifying, the workforce is buckling, and health ODA faces its steepest cuts on record.

Key Lessons From 2026 Data

• The United States spends 18.0% of GDP on healthcare by CMS's measure — nearly double the OECD average — yet ranks near the bottom on life expectancy and affordability among peer nations
• India spends 1.8% of GDP on health, less than half of Brazil (10%) and South Africa (9%), and below Russia (7%) and China (6%)
• The world faces a shortfall of 11 million health professionals by 2030, with 61% of healthcare workers currently reporting burnout
• Health ODA is projected to fall 29–46% from 2024 to 2026

The most powerful argument for health AI is not cost savings or diagnostic speed — it is workforce survival. The coming decade demands that the question shift from whether AI can replace clinicians to how it can help keep them. Human capital is the central lever of health outcomes. Healthcare is both a moral imperative and an economic necessity — the path forward requires political will, sustained investment, and a genuine commitment to serving the common man.

11. References

Reports and Official Publications

1. Economics by Design (2026). Health Spending (% GDP) By Country. EBD Place Based Value. Accessed 23 July 2026.

2. OECD (2026). Restoring Public Finances: Executive Summary. OECD Publishing, Paris.

3. OECD (2026). ODA projections for 2026 and the near-term. OECD Publishing, Paris.

4. Devex (2026). Health ODA faces steepest cuts in 2026, OECD says. 22 June 2026.

5. OECD iLibrary (2026). The latest 2026 ODA projections reveal aid for health is further at risk.

6. Peterson-KFF Health System Tracker (2026). How does health spending in the U.S. compare to other countries?

7. Centers for Medicare and Medicaid Services (2026). National Health Expenditure Accounts, 2024.

Academic and Peer-Reviewed

8. Quality & Quantity (2026). Health equity in emerging markets: a comparative analysis of financing, human capital, and digital readiness. Springer. 2 July 2026.

Workforce and Burnout

9. Rozen, M. (2026). Healthcare Burnout in 2026 — Why 61% of Healthcare Workers Are Still Burning Out.

10. Nurse.com (2026). 2026 Nurse Burnout Statistics: Rates, Causes, & Trends.

11. Healthcare Dive (2026). Burnout is increasing, while employee confidence is at a record low. 20 May 2026.

12. HealthLeaders Media (2026). The Majority of Nurses Report Feeling Emotionally Exhausted at Work. 23 March 2026.

Country-Specific

13. Forbes India (2026). India's health, education spending lags BRICS peers despite economic growth. 30 January 2026.

14. BRICS Connect (2026). India's spending on health and education trails BRICS peers. 1 February 2026.

Health Spending Data

15. Wikiwand (2026). Health spending as percent of GDP by country. Data from OECD Health Statistics.

16. Strive Edge IAS (2026). Public Health Financing — India.

Global Health Financing

17. Australian Global Health Alliance (2026). Global Health in the 2026-27 Federal Budget Analysis. 22 May 2026.

18. CNBC Africa (2026). Africa's Health Financing Paradox: Plenty of Capital, Too Little Investment. 14 May 2026.

World Health Organization

19. WHO (2026). Health workforce. who.int/health-topics/health-workforce.

Health Economics (Section 8)

20. Partnership to Fight Chronic Disease (2025). Chronic Disease Could Cost the U.S. $47 Trillion Over Next 15 Years. December 2025.

21. Centers for Disease Control and Prevention (2026). Fast Facts: Health and Economic Costs of Chronic Conditions.

22. Bloom, D. et al. (as cited 2026). The Global Economic Burden of Non-communicable Diseases, 2010–2030. WEF / Harvard School of Public Health.

23. HealthManagement.org (2026). Health Investment as an Engine of Growth. 4 March 2026.

24. McKinsey & Company (2026), as cited in Makebot.ai: AI Could Save the Healthcare Industry $360 Billion Annually. 18 March 2026.

25. National Bureau of Economic Research (as cited 2026). The Potential Impact of Artificial Intelligence on Healthcare Spending.

26. Health Affairs Scholar (2026), as cited in Paubox: Can AI Make Healthcare Cheaper, or Will Businesses Keep the Savings?

27. Sully.ai (2026). Cut Healthcare Administrative Costs with Workflow Automation. 27 May 2026.

About the Author

Pawan Bhatia is the founder of NextGen Economics, an independent research platform publishing long-horizon analysis on capital, technology, and the forces shaping the next decade of wealth creation.

His work is guided by a singular vision: a world in which the quality and distribution of economic thinking is radically improved — a 1Q world, in which better questions lead to better outcomes. Medicine & The Common Man is the ninth paper in that project.

This paper was compiled with the assistance of AI tools for data synthesis, drafting, and formatting. All arguments, policy recommendations, and editorial decisions — including a correction to the paper's own draft GDP figure, made openly rather than silently — are the author's own.

Contact: pawan.bhatia@nextgeneconomics.com · www.nextgeneconomics.com

Publisher's Note

NextGen Economics is an independent research platform dedicated to producing evidence-based, accessible, and actionable research on the societal implications of technological and economic change. We are committed to intellectual independence. No corporate funding, advisory relationships, or consulting engagements influenced the analysis or conclusions presented in this document.

This white paper is the ninth in NGE's white paper series, following prior work on AI alignment, equity markets, technology infrastructure, and consciousness studies.

Disclaimer

This white paper is for informational purposes only. The views expressed herein are those of the author and do not necessarily reflect the views of any affiliated organisations. This document does not constitute legal, medical, or policy endorsement advice.

AI Tools Disclaimer: This white paper was developed with the assistance of AI-powered research and writing tools, including large language models for literature synthesis, drafting, and formatting. All substantive arguments, policy recommendations, empirical claims, and final editorial decisions remain the sole responsibility of the author. The use of AI tools does not imply endorsement of the content by any AI system or its developers.

Reproduction and Distribution: This white paper is licensed under Creative Commons Attribution-NonCommercial 4.0 International License. You are free to share, adapt, and distribute this work for non-commercial purposes, provided you attribute the author appropriately.